DKK1 and chronic kidney disease: By binding to LRP5/6 or forming a tertiary complex with LRP5/6, sclerostin and DKK1, respectively, exerted their role in modulating the cross-talk of CKD-related bone disease and vasculatures with the results of vascular smooth muscle cells trans-differentiation and vascular calcification [7,11,15,31].